Your browser doesn't support javascript.
loading
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Di Ciaccio, Pietro R; Polizzotto, Mark N; Cwynarski, Kate; Gerrie, Alina S; Burton, Catherine; Bower, Mark; Kuruvilla, John; Montoto, Silvia; McKay, Pam; Fox, Christopher P; Milliken, Samuel; Jiamsakul, Awachana; Osborne, Wendy; Collins, Graham P; Manos, Kate; Linton, Kim M; Iyengar, Sunil; Kassam, Shireen; Limei, Michelle Poon; Kliman, David; Wong Doo, Nicole; Watson, Anne-Marie; Fedele, Pasquale; Yannakou, Costas K; Hunt, Stewart; Ku, Matthew; Sehn, Laurie H; Smith, Alexandra; Renshaw, Hanna; Maxwell, Alice; Liu, Qin; Dhairyawan, Rageshri; Ferguson, Graeme; Pickard, Keir; Painter, Daniel; Thakrar, Nisha; Song, Kevin W; Hamad, Nada.
Afiliación
  • Di Ciaccio PR; Department of Haematology, The Canberra Hospital, Garran, ACT, Australia.
  • Polizzotto MN; College of Health and Medicine, Australian National University, Canberra, ACT, Australia.
  • Cwynarski K; Department of Haematology, The Canberra Hospital, Garran, ACT, Australia.
  • Gerrie AS; John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
  • Burton C; Department of Haematology, University College Hospital, London, United Kingdom.
  • Bower M; Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, BC, Canada.
  • Kuruvilla J; Department of Haematology, St James University Hospital, Leeds, United Kingdom.
  • Montoto S; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom.
  • McKay P; Division of Oncology and Haematology, Princess Margaret Cancer Centre, The Princess Margaret Hospital, Toronto, ON, Canada.
  • Fox CP; Department of Haemato-oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Milliken S; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • Jiamsakul A; University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Osborne W; School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Collins GP; Department of Haematology, St Vincent's Hospital, Sydney, NSW, Australia.
  • Manos K; The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
  • Linton KM; Department of Haematology, Freeman Hospital, Newcastle upon Tyne NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom.
  • Iyengar S; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Kassam S; Department of Haematology, Flinders Medical Centre, Adelaide, SA, Australia.
  • Limei MP; The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom.
  • Kliman D; Manchester Cancer Research Centre, University of Manchester, Manchester, United Kingdom.
  • Wong Doo N; Manchester Academic Health Science Centre, Manchester, United Kingdom.
  • Watson AM; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Fedele P; King's College Hospital, London, United Kingdom.
  • Yannakou CK; Department of Haematology, National University Hospital, Singapore.
  • Hunt S; Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Ku M; Department of Haematology, Concord Repatriation General Hospital, Sydney, NSW, Australia.
  • Sehn LH; Faculty of Medicine, University of Sydney, Sydney, NSW, Australia.
  • Smith A; Department of Haematology, Liverpool Hospital, Sydney, NSW, Australia.
  • Renshaw H; School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
  • Maxwell A; Haematology Department, Monash Health, Clayton, VIC, Australia.
  • Liu Q; Department of Molecular Oncology and Cancer Immunology, Epworth Freemasons Hospital, Epworth HealthCare, Melbourne, Victoria, Australia.
  • Dhairyawan R; Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
  • Ferguson G; Department of Haematology, St Vincent's Hospital, Melbourne, VIC, Australia.
  • Pickard K; Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, BC, Canada.
  • Painter D; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.
  • Thakrar N; Department of Haematology, University College Hospital, London, United Kingdom.
  • Song KW; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom.
  • Hamad N; Division of Oncology and Haematology, Princess Margaret Cancer Centre, The Princess Margaret Hospital, Toronto, ON, Canada.
Blood ; 143(2): 152-165, 2024 Jan 11.
Article en En | MEDLINE | ID: mdl-37832030
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / Infecciones por Virus de Epstein-Barr / Linfoma Plasmablástico Límite: Humans / Middle aged Idioma: En Revista: Blood Año: 2024 Tipo del documento: Article País de afiliación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / Infecciones por Virus de Epstein-Barr / Linfoma Plasmablástico Límite: Humans / Middle aged Idioma: En Revista: Blood Año: 2024 Tipo del documento: Article País de afiliación: Australia